CTCBIO Inc. (KOSDAQ:060590)
7,160.00
0.00 (0.00%)
At close: Sep 18, 2025
CTCBIO Revenue
CTCBIO had revenue of 30.91B KRW in the quarter ending June 30, 2025, with 7.66% growth. This brings the company's revenue in the last twelve months to 148.10B, up 20.40% year-over-year. In the year 2024, CTCBIO had annual revenue of 144.41B with 4.74% growth.
Revenue (ttm)
148.10B
Revenue Growth
+20.40%
P/S Ratio
1.16
Revenue / Employee
597.16M
Employees
248
Market Cap
171.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 144.41B | 6.53B | 4.74% |
Dec 31, 2023 | 137.88B | -27.33B | -16.54% |
Dec 31, 2022 | 165.21B | 24.89B | 17.74% |
Dec 31, 2021 | 140.32B | 10.29B | 7.91% |
Dec 31, 2020 | 130.03B | -6.09B | -4.48% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hanwha Aerospace | 19.25T |
Hyundai Motor Company | 182.25T |
HD Hyundai Heavy Industries | 15.58T |
KB Financial Group | 14.92T |